Tina Etcheverry, PhDAdjunct Professor/Faculty Advisor, Team Master's Project
Product Development in Biotechnology, Technology Transfer, Cell Culture Process Design, Molecular Biology and Biochemistry
Dr. Etcheverry, originally from Seattle, Washington, received her undergraduate degree in Biochemistry from UC Berkeley in 1975 and her PhD degree in Biochemistry, Molecular Biology and Biophysics from Cornell University in 1980. In 2007, she retired from Genentech after 25 years of leading process development groups in cell culture and providing tech transfer expertise to international partners. She is recognized for her leadership role as Chemistry, Manufacturing and Controls (CMC) team leader for three products. These teams were instrumental in bringing TNKase, Xolair and Lucentis from concept to market. She currently works as a consultant with multiple biotech companies, providing consulting services on product development strategies and resolving process issues.She also serves on the Board of Directors for Biotech Partners, a non-profit organization that offers a specialized science and technology curriculum for under-represented youth in the biotechnology field. Since September 2011, Dr. Etcheverry has served as an Adjunct Faculty member at KGI for the Team Master Projects.
Chaderjian, Chin, Harris, and Etcheverry. 2005. Effect of copper sulfate on performance of a serum-free CHO cell culture process and the level of free thiol in the recombinanct antibody expressed. Biotechnology Progress. 21(2):550-3.
O'Leary, Etcheverry, Bezy, Anicetti and Burton. 2001. Use of pilot plant facilities to aid validation programs. PDA Journal of Pharm Sci and Technology 55(4):230-4.
DelaCruz, Crupi, and Etcheverry. 2001. Factorial Design and Analysis for Rapid Development of an Antibody Production Process in CHO Cells. In: Animal Cell Technology: From Target to Market. Lindner-Olsson, Chatzissavidou and Lullau (eds) Kluwer Academic Publishers, 279-286.
Ryll, T. Dutina, G. Reyes, A. Gunson, J. Krummen,L. Etcheverry, T. 2000. Performance of small-scale CHO perfusion cultures using an acoustic cell filtration device for cell retention: characterization of separation efficiency and impact of perfusion on product quality. Biotechnology & Bioengineering 69: 440-449.
Santell, Ryll, Etcheverry, Sartoris, Dutina, Wang, Gunson and Warner. 1999. Aberrant metabolic sialylation of recombinant proteins expressed in Chisese hamster ovary cells in high productivity cultures. BBRC 258: 132-137.
Moore, Mercer, Dutina, Donahue, Bauer, Mather, Etcheverry and Ryll. 1997. Effects of temperature shift on cell cycle, apoptosis and nucleotide pools in CHO cell cultures. Cytotechnology 23: 47-54.
Etcheverry. 1996. Expression of Engineered Proteins in Mammalian Cell Culture, pp.163-181. In: Protein Engineering: Principles and Practice. Cleland and Craik (eds.) Wiley-Liss.
Keyt, Paoni, Refino, Ogez, Etcheverry, Botstein and Bennett. 1994. A Faster-Acting and More Potent Form of Tissue Plasminogen Activator. PNAS 91: 3670-3674.
Wurm, Johnson, Etcheverry, Lie and Petropoulos. 1994. Retrotargeting: Use of defective retroviral DNA fragments to improve recombinant protein production in mammalian cells. In: Animal Cell Technology: Products for Today and the Future. Spier, Griffiths, and Berthold (eds.) Oxford.Etcheverry. 1990. Induced Expression Using the Yeast Copper Metallothionein Promoter. In: Methods in Enzymology 185. Goeddel (ed.). Academic Press, Inc. San Diego.
|Tina Etcheverry, PhD|